Comparative Study on Signal Transduction in Endothelial Cells After Anti-A/B and Human Leukocyte Antigen Antibody Reaction: Implication of Accommodation

Background. Recent development of immunosuppressive therapy has provided a platform for clinical human leukocyte antigen (HLA)- and ABO-incompatible kidney transplantation. However, the prognosis seems to be different between the two. Accommodation, the condition of no injury even in the presence of antidonor antibody, is one of the key factors for successful transplantation with antidonor antibody. The purpose of this study was to compare signal transduction between anti-A/B and anti-HLA antibody reaction and to elucidate the mechanisms underlying accommodation. Methods. Blood type A- or B-transferase gene was transfected into human EA.hy926 endothelial cells. After cell sorting, A- or B-expressing cells at high levels were obtained. The effects of anti-HLA and anti-A/B antibody binding on complement-mediated cytotoxicity and signal transduction were examined. Results. Preincubation with anti-HLA antibodies only at low levels (<10% of saturation level) or anti-A/B antibodies at high levels (even at near saturation levels) for 24 hr resulted in resistance to complement-mediated cytotoxicity. Anti-A/B antibody ligation inactivated ERK1/2 pathway and increased complement regulatory proteins such as CD55 and CD59, whereas anti-HLA ligation activated PI3K/AKT pathway and increased cytoprotective genes such as hemeoxygenase-1 and ferritin H. Conclusion. Complement inhibition by upregulation of CD55 and CD59 through ERK1/2 inactivation might play a substantial role in accommodation after ABO-incompatible transplantation, which could also explain the intriguing finding of C4d deposition in the graft without rejection.

[1]  A. Lu,et al.  Desensitization protocols and their outcome. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[2]  Jining Liu,et al.  Is there a clinical need for a diagnostic test allowing detection of chain type–specific anti‐A and anti‐B? (CME) , 2011, Transfusion.

[3]  Takaaki Kobayashi,et al.  Significant association between chronic antibody-mediated rejection and donor-specific antibodies against HLA-DRB rather than DQB in renal transplantation. , 2011, Human immunology.

[4]  R. Colvin,et al.  Emerging role of B cells in chronic allograft dysfunction. , 2010, Kidney international. Supplement.

[5]  R. Montgomery,et al.  Renal Transplantation Across HLA and ABO Antibody Barriers: Integrating Paired Donation into Desensitization Protocols , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  Walter K. Kremers,et al.  Baseline Donor‐Specific Antibody Levels and Outcomes in Positive Crossmatch Kidney Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  A. Nakao,et al.  Significance of HLA class I antibody-induced antioxidant gene expression for endothelial cell protection against complement attack. , 2010, Biochemical and biophysical research communications.

[8]  E. Reed,et al.  Effect of Antibodies on Endothelium , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  J. Platt,et al.  The role of antibodies in transplantation. , 2009, Transplantation reviews.

[10]  D. Segev,et al.  ABO‐incompatible deceased donor liver transplantation in the United States: A national registry analysis , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[11]  B. Kaplan,et al.  Recent Developments in Kidney Transplantation—A Critical Assessment , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  P. Gianello,et al.  Accommodation and antibodies. , 2009, Transplant immunology.

[13]  A. Griesemer,et al.  Upregulation of CD59: Potential Mechanism of Accommodation in a Large Animal Model , 2009, Transplantation.

[14]  S. Jordan,et al.  Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients. , 2009, Contributions to nephrology.

[15]  P. Flevaris,et al.  Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway. , 2009, Blood.

[16]  D. Segev,et al.  C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. , 2009, Journal of the American Society of Nephrology : JASN.

[17]  R. Colvin,et al.  Kidney transplantation: mechanisms of rejection and acceptance. , 2008, Annual review of pathology.

[18]  D. Wishart,et al.  Transplant Glomerulopathy, Late Antibody‐Mediated Rejection and the ABCD Tetrad in Kidney Allograft Biopsies for Cause , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  E. Reed,et al.  Anti-HLA Antibodies Can Induce Endothelial Cell Survival or Proliferation Depending on their Concentration , 2006, Transplantation.

[20]  T. Mohanakumar,et al.  HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway. , 2006, Transplant immunology.

[21]  Li Zhao,et al.  Oncogenic PI3K deregulates transcription and translation , 2005, Nature Reviews Cancer.

[22]  A. Dalmasso,et al.  Characteristics of CD59 up‐regulation induced in porcine endothelial cells by αGal ligation and its association with protection from complement , 2003, Xenotransplantation.

[23]  M. Stegall,et al.  Accommodation in ABO‐Incompatible Kidney Allografts, a Novel Mechanism of Self‐Protection Against Antibody‐Mediated Injury , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  M. Laffan,et al.  Human Umbilical Vein Endothelial Cells Differ from Other Endothelial Cells in Failing to Express ABO Blood Group Antigens , 2000, Journal of Vascular Research.